ABBV - AbbVie - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABBV is currently covered by 23 analysts with an average price target of $210.66. This is a potential upside of $27.4 (14.95%) from yesterday's end of day stock price of $183.26.

AbbVie's activity chart (see below) currently has 410 price targets and 356 ratings on display. The stock rating distribution of ABBV is 84.71% BUY and 15.29% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.44% with an average time for these price targets to be met of 485.82 days.

Highest price target for ABBV is $250, Lowest price target is $181, average price target is $208.48.

Most recent stock forecast was given by GEOFF MEACHAM from CITI on 14-May-2025.

Currently out of the existing stock ratings of ABBV, 72 are a BUY (84.71%), 13 are a HOLD (15.29%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$205

$20.98 (11.40%)

$215

9 days ago
(14-May-2025)

12/14 (85.71%)

$27.59 (15.55%)

285

Buy

$216

$31.98 (17.38%)

$214

24 days ago
(29-Apr-2025)

23/26 (88.46%)

$22.49 (11.62%)

431

Buy

$250

$65.98 (35.85%)

$241

25 days ago
(28-Apr-2025)

12/18 (66.67%)

$57.66 (29.98%)

526

Buy

$240

$55.98 (30.42%)

$210

2 months 18 days ago
(05-Mar-2025)

7/8 (87.5%)

$28.46 (13.45%)

474

Hold

$223

$38.98 (21.18%)

$191

2 months 19 days ago
(04-Mar-2025)

3/4 (75%)

$15.71 (7.58%)

443

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABBV (AbbVie) average time for price targets to be met?

On average it took 485.82 days on average for the stock forecasts to be realized with a an average price target met ratio 92.44

Which analyst has the current highest performing score on ABBV (AbbVie) with a proven track record?

JOHN BORIS

Which analyst has the most public recommendations on ABBV (AbbVie)?

John Boris has 8 price targets and 5 ratings on ABBV

Which analyst is the currently most bullish on ABBV (AbbVie)?

Terence Flynn with highest potential upside - $65.98

Which analyst is the currently most reserved on ABBV (AbbVie)?

Alex Arfaei with lowest potential downside - -$105.02

AbbVie in the News

AbbVie Inc. (ABBV): Among the Best Income Stocks to Invest in Now

We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best income stocks. Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy....

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Vertex Pharmaceuticals (NASDAQ:VRTX). Over the next few years, therapeutic companies, which develop a wide variety of treatments...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?